A
Anton F. H. Stalenhoef
Researcher at Radboud University Nijmegen Medical Centre
Publications - 275
Citations - 19979
Anton F. H. Stalenhoef is an academic researcher from Radboud University Nijmegen Medical Centre. The author has contributed to research in topics: Cholesterol & Lipoprotein. The author has an hindex of 69, co-authored 275 publications receiving 18496 citations. Previous affiliations of Anton F. H. Stalenhoef include University of Pennsylvania & Henry Ford Hospital.
Papers
More filters
Journal ArticleDOI
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society
Børge G. Nordestgaard,M. John Chapman,Steve E. Humphries,Henry N. Ginsberg,Luis Masana,Olivier S. Descamps,Olov Wiklund,Robert A. Hegele,Frederick J. Raal,Joep C. Defesche,Albert Wiegman,Raul D. Santos,Gerald F. Watts,Klaus G. Parhofer,G. Kees Hovingh,Petri T. Kovanen,Catherine Boileau,Maurizio Averna,Jan Borén,Eric Bruckert,Alberico L. Catapano,Jan Albert Kuivenhoven,Jan Albert Kuivenhoven,P. Pajukanta,Kausik K. Ray,Anton F. H. Stalenhoef,Erik S.G. Stroes,Marja-Riitta Taskinen,Anne Tybjærg-Hansen +28 more
TL;DR: There is an urgent worldwide need for diagnostic screening together with early and aggressive treatment of this extremely high-risk condition, familial hypercholesterolaemia.
Journal ArticleDOI
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
John J.P. Kastelein,Fatima Akdim,Erik S.G. Stroes,Aeilko H. Zwinderman,Michiel L. Bots,Anton F. H. Stalenhoef,Frank L.J. Visseren,Eric J.G. Sijbrands,Mieke D. Trip,Evan A. Stein,Daniel Gaudet,Raphaël Duivenvoorden,Enrico P. Veltri,A. David Marais,Eric de Groot +14 more
TL;DR: In patients with familial hypercholesterolemia, combined therapy with ezetimibe and simVastatin did not result in a significant difference in changes in intima-media thickness, as compared with simvastatin alone, despite decreases in levels of LDL cholesterol and C-reactive protein.
Journal ArticleDOI
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
Marina Cuchel,Eric Bruckert,Henry N. Ginsberg,Frederick J. Raal,Raul D. Santos,Robert A. Hegele,Jan Albert Kuivenhoven,Børge G. Nordestgaard,Olivier S. Descamps,Elisabeth Steinhagen-Thiessen,Anne Tybjærg-Hansen,Gerald F. Watts,Maurizio Averna,Catherine Boileau,Jan Borén,A.L. Catapano,Joep C. Defesche,G. Kees Hovingh,Steve E. Humphries,Petri T. Kovanen,Luis Masana,Päivi Pajukanta,Klaus G. Parhofer,Kausik K. Ray,Anton F. H. Stalenhoef,Erik S.G. Stroes,Marja-Riitta Taskinen,Albert Wiegman,Olov Wiklund,M. John Chapman +29 more
TL;DR: In this article, the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society (EAS) critically reviewed available data with the aim of providing clinical guidance for the recognition and management of HoFH.
Journal ArticleDOI
The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk
Calin D. Popa,Mihai G. Netea,Piet L. C. M. van Riel,Jos W. M. van der Meer,Anton F. H. Stalenhoef +4 more
TL;DR: Investigations assessing the impact of anti-TNF agents on intermediary metabolism suggest that TNF-alpha blockade may improve insulin resistance and lipid profiles in patients with chronic inflammatory diseases.
Journal ArticleDOI
Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.
Lars Berglund,John D. Brunzell,Anne C. Goldberg,Ira J. Goldberg,Frank M. Sacks,Mohammad Hassan Murad,Anton F. H. Stalenhoef +6 more
TL;DR: In this paper, the authors developed clinical practice guidelines on hypertriglyceridemia based on systematic reviews of evidence, e-mail discussion, conference calls, and one in-person meeting.